Steroid Receptor RNA Activator 1 (SRA1) (Middle Region) Peptid
Kurzübersicht für Steroid Receptor RNA Activator 1 (SRA1) (Middle Region) Peptid (ABIN984402)
Target
Spezies
Quelle
Applikation
-
-
Protein Region
- Middle Region
-
Sequenz
- SGPASGVEPT SFPVESEAVM EDVLRPLEQA LEDCRGHTRK QVCDDISRRL
-
Produktmerkmale
- This is a synthetic peptide designed for use in combination with anti-SRA1 Antibody. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
-
Aufreinigung
- Purified
-
-
-
-
Applikationshinweise
- Each Investigator should determine their own optimal working dilution for specific applications.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Lyophilized
-
Rekonstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
-
Konzentration
- 1 mg/mL
-
Buffer
- Final peptide concentration is 1 mg/mL in PBS.
-
Handhabung
- Avoid repeated freeze-thaw cycles.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
-
- SRA1 (Steroid Receptor RNA Activator 1 (SRA1))
-
Hintergrund
-
This gene is involved in transcriptional coactivation by steroid receptors. There is currently data suggesting this gene encodes both a non-coding RNA that functions as part of a ribonucleoprotein complex and a protein coding mRNA. Increased expression of both the transcript and the protein is associated with cancer.
Alias Symbols: MGC87674, SRA, SRAP, STRAA1, pp7684
Protein Size: 236 -
Molekulargewicht
- 26 kDa
-
Gen-ID
- 10011
-
NCBI Accession
- NM_001035235, NP_001030312
-
UniProt
- Q9HD15
Target
-